Debt-to-equity in % of American Oncology Network, Inc. from Q3 2021 to Q4 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
American Oncology Network, Inc. quarterly Debt-to-equity history and change rate from Q3 2021 to Q4 2024.
  • American Oncology Network, Inc. Debt-to-equity for the quarter ending December 31, 2024 was -404 %, a 239% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

American Oncology Network, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2024 -404 -285 -239% Dec 31, 2024
Q3 2024 -293 -139 -89.5% Sep 30, 2024
Q2 2024 -190 +349 +64.8% Jun 30, 2024
Q1 2024 -144 +357 +71.2% Mar 31, 2024
Q4 2023 -119 +398 +76.9% Dec 31, 2023
Q3 2023 -155 +199 +56.3% Sep 30, 2023
Q2 2023 -539 -207 -62.5% Jun 30, 2023
Q1 2023 -501 -191 -61.8% Mar 31, 2023
Q4 2022 -517 -234 -82.4% Dec 31, 2022
Q3 2022 -354 -246 -229% Sep 30, 2022
Q2 2022 -331 Jun 30, 2022
Q1 2022 -310 Mar 31, 2022
Q4 2021 -284 Dec 31, 2021
Q3 2021 -108 Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.